Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 04-Feb-20 11:45 AM View:  | Fiorino Anthony S. Director | Immune Pharmaceuticals, Inc. (IMNPQ) | 03-Feb-20 | Sale | 75,000 | $0.00 | $262.50 | (100%) 75.0K to 0 | |
| 23-May-18 1:16 PM View: | Fiorino Anthony S. Chief Medical Officer and COO | Immune Pharmaceuticals, Inc. (IMNPQ) | 22-May-18 | Market Purchase | 25,000 | $0.24 | $5,977.50 | 50% 50.0K to 75.0K | |
| 18-May-18 3:32 PM View: | Fiorino Anthony S. Chief Medical Officer and COO | Immune Pharmaceuticals, Inc. (IMNPQ) | 17-May-18 | Market Purchase | 50,000 | $0.26 | $12,900.00 | 100% 0 to 50.0K | |
| 04-Jan-17 5:09 PM View: | Kazado Daniel Director | Immune Pharmaceuticals, Inc. (IMNPQ) | 04-Jan-17 | Market Purchase | 76,503 | $0.19 | $14,221.90 | 7% 1.07M to 1.15M | |
| 20-Dec-16 8:44 PM View: | Kazado Daniel Director | Immune Pharmaceuticals, Inc. (IMNPQ) | 16-Dec-16 | Market Purchase | 161,377 | $0.19 | $30,000.00 | 18% 907.29K to 1.07M | (3%) |
| 11-Oct-16 6:10 PM View: | Teper Daniel Gedeon CEO Director 10% Owner | Immune Pharmaceuticals, Inc. (IMNPQ) | 06-Oct-16 | Option Exercise | 185,473 | $0.04 | $7,418.92 | 3% 5.68M to 5.87M | |
| 04-Aug-16 9:41 PM View: | Kazado Daniel Director | Immune Pharmaceuticals, Inc. (IMNPQ) | 04-Aug-16 | Purchase | 666,667 | $0.45 | $300,000.00 | 277% 240.62K to 907.29K | |
| 04-Aug-16 9:41 PM View: | Luchi Monica E. EVP & CMO | Immune Pharmaceuticals, Inc. (IMNPQ) | 04-Aug-16 | Purchase | 777,778 | $0.45 | $350,000.00 | 100% 0 to 777.78K | |
| 04-Aug-16 9:42 PM View: | Teper Daniel Gedeon CEO Director 10% Owner | Immune Pharmaceuticals, Inc. (IMNPQ) | 04-Aug-16 | Market Purchase | 937,500 | $0.38 | $356,250.00 | 19% 4.81M to 5.75M | (5%) |
| 26-Jan-16 5:12 PM View: | Teper Daniel Gedeon CEO Director 10% Owner | Immune Pharmaceuticals, Inc. (IMNPQ) | 26-Jan-16 | Market Purchase (Planned) | 42,000 | $0.59 | $24,826.20 | < 1% 4.77M to 4.81M | (4%) |
| 19-Jan-16 6:39 PM View: | Teper Daniel Gedeon CEO Director 10% Owner | Immune Pharmaceuticals, Inc. (IMNPQ) | 19-Jan-16 | Market Purchase (Planned) | 44,200 | $0.57 | $24,999.50 | < 1% 4.72M to 4.77M | (5%) |
| 12-Jan-16 9:26 PM View: | Teper Daniel Gedeon CEO Director 10% Owner | Immune Pharmaceuticals, Inc. (IMNPQ) | 12-Jan-16 | Market Purchase (Planned) | 39,400 | $0.62 | $24,597.40 | < 1% 4.69M to 4.72M | (7%) |
| 06-Jan-16 8:30 AM View: | Teper Daniel Gedeon CEO Director 10% Owner | Immune Pharmaceuticals, Inc. (IMNPQ) | 05-Jan-16 | Market Purchase (Planned) | 62,000 | $0.81 | $49,972.00 | 1% 4.62M to 4.69M | (2%) |
| 08-Dec-15 5:20 PM View: | Kazado Daniel Director | Immune Pharmaceuticals, Inc. (IMNPQ) | 07-Dec-15 | Market Purchase | 150,000 | $0.78 | $117,105.00 | 166% 90.62K to 240.62K | (1%) |
| 08-Dec-15 5:25 PM View: | Teper Daniel Gedeon CEO Director 10% Owner | Immune Pharmaceuticals, Inc. (IMNPQ) | 07-Dec-15 | Market Purchase | 65,400 | $0.76 | $49,926.40 | 1% 4.56M to 4.62M | < 1% |
| 26-Oct-15 6:03 PM View: | Teper Daniel Gedeon CEO Director 10% Owner | Immune Pharmaceuticals, Inc. (IMNPQ) | 26-Oct-15 | Market Purchase (Planned) | 18,400 | $1.36 | $25,000.10 | < 1% 4.54M to 4.56M | (5%) |
| 19-Oct-15 5:45 PM View: | Teper Daniel Gedeon CEO Director | Immune Pharmaceuticals, Inc. (IMNPQ) | 19-Oct-15 | Market Purchase (Planned) | 18,600 | $1.34 | $24,998.40 | < 1% 4.52M to 4.54M | (3%) |
| 13-Oct-15 7:53 AM View: | Teper Daniel Gedeon CEO Director 10% Owner | Immune Pharmaceuticals, Inc. (IMNPQ) | 12-Oct-15 | Market Purchase (Planned) | 19,000 | $1.30 | $24,707.60 | < 1% 4.5M to 4.52M | (2%) |
| 05-Oct-15 6:24 PM View: | Teper Daniel Gedeon CEO Director 10% Owner | Immune Pharmaceuticals, Inc. (IMNPQ) | 05-Oct-15 | Market Purchase (Planned) | 40,700 | $1.23 | $49,926.70 | < 1% 4.46M to 4.5M | (8%) |
| 16-Sep-15 5:17 PM View: | Kazado Daniel Director | Immune Pharmaceuticals, Inc. (IMNPQ) | 14-Sep-15 | Market Purchase | 50,000 | $1.47 | $73,480.00 | 123% 40.62K to 90.62K | < 1% |
| 16-Sep-15 5:17 PM View: | Azria Rene Pierre Director | Immune Pharmaceuticals, Inc. (IMNPQ) | 14-Sep-15 | Market Purchase | 50,000 | $1.48 | $73,850.00 | 100% 0 to 50.0K | (< 1%) |
| 01-Sep-15 6:42 PM View: | Teper Daniel Gedeon CEO Director 10% Owner | Immune Pharmaceuticals, Inc. (IMNPQ) | 01-Sep-15 | Market Purchase | 7,569 | $1.29 | $9,798.83 | < 1% 4.45M to 4.46M | 2% |
| 31-Jul-15 6:00 PM View: | Kazado Daniel Director | Immune Pharmaceuticals, Inc. (IMNPQ) | 15-Jul-15 | Conversion | 14,656 | $1.51 | $22,130.60 | 175% 8.39K to 23.05K | |
| 31-Jul-15 6:00 PM View: | Teper Daniel Gedeon CEO Director 10% Owner | Immune Pharmaceuticals, Inc. (IMNPQ) | 08-Jul-15 | Conversion | 8,905 | $1.51 | $13,446.50 | < 1% 4.44M to 4.45M | |
| 12-Jan-15 5:16 PM View: | Sidransky David Director | Immune Pharmaceuticals, Inc. (IMNPQ) | 08-Jan-15 | Grant | 3,409 | -- | -- | 19% 18.29K to 21.7K | |
| 03-Dec-14 5:04 PM View: | Berdugo Gad Director | Immune Pharmaceuticals, Inc. (IMNPQ) | 26-Nov-14 | Market Purchase | 8,000 | $2.50 | $20,000.00 | 100% 0 to 8.0K | 40% |
| 03-Dec-14 5:09 PM View: | Kazado Daniel Director | Immune Pharmaceuticals, Inc. (IMNPQ) | 26-Nov-14 | Market Purchase | 8,000 | $2.50 | $20,000.00 | 2041% 0.39K to 8.39K | 40% |
| 03-Dec-14 5:06 PM View: | Stancic Ana Director | Immune Pharmaceuticals, Inc. (IMNPQ) | 26-Nov-14 | Market Purchase | 8,000 | $2.50 | $20,000.00 | 100% 0 to 8.0K | 40% |
| 03-Dec-14 4:54 PM View: | Sidransky David Director | Immune Pharmaceuticals, Inc. (IMNPQ) | 26-Nov-14 | Market Purchase | 10,400 | $2.50 | $26,000.00 | 132% 7.89K to 18.29K | 40% |
| 03-Dec-14 5:00 PM View: | Durrant Cameron Director | Immune Pharmaceuticals, Inc. (IMNPQ) | 26-Nov-14 | Market Purchase | 4,000 | $2.50 | $10,000.00 | 100% 0 to 4.0K | 40% |
| 27-Aug-13 5:13 PM View: | Teper Daniel Gedeon Chairman & CEO Director | Immune Pharmaceuticals, Inc. (IMNPQ) | 25-Aug-13 | Grant | 4,260,560 | -- | -- | 100% 0 to 4.26M | |
| 28-Aug-13 12:09 PM View: | Sidransky David Director | Immune Pharmaceuticals, Inc. (IMNPQ) | 25-Aug-13 | Grant | 5,951 | -- | -- | 100% 0 to 5.95K | |
| 14-Aug-13 5:38 PM View: | Dunton Alan W Director | Immune Pharmaceuticals, Inc. (IMNPQ) | 12-Aug-13 | Grant | 525,000 | -- | -- | 292% 180.0K to 705.0K | |
| 14-Aug-13 5:45 PM View: | Brownlie Keith L Director | Immune Pharmaceuticals, Inc. (IMNPQ) | 12-Aug-13 | Grant | 300,000 | -- | -- | 500% 60.0K to 360.0K | |
| 14-Aug-13 5:50 PM View: | Savage Robert G Director | Immune Pharmaceuticals, Inc. (IMNPQ) | 12-Aug-13 | Grant | 300,000 | -- | -- | 171% 175.3K to 475.3K | |
| 28-Dec-12 3:37 PM View: | Allard Stephane Chief Medical Officer | Immune Pharmaceuticals, Inc. (IMNPQ) | 27-Dec-12 | Option Exercise | 350,000 | -- | -- | 518% 67.51K to 417.51K | |
| 28-Dec-12 3:48 PM View: | Cook Robert W Interim Chief Exec. Officer Director | Immune Pharmaceuticals, Inc. (IMNPQ) | 27-Dec-12 | Option Exercise | 450,000 | -- | -- | 819% 54.96K to 504.96K | |
| 05-Jan-12 3:23 PM View: | Dunton Alan W Director | Immune Pharmaceuticals, Inc. (IMNPQ) | 03-Jan-12 | Grant | 75,000 | -- | -- | 100% 0 to 75.0K | |
| 13-Dec-07 3:57 PM View: | Cook Robert W CFO-SVP, Finance & Admin. | Immune Pharmaceuticals, Inc. (IMNPQ) | 13-Dec-07 | Market Purchase | 5,000 | $1.35 | $6,750.00 | 50% 10.0K to 15.0K | (41%) |
| 13-Dec-07 3:59 PM View: | Talley John V President, CEO & Director Director | Immune Pharmaceuticals, Inc. (IMNPQ) | 13-Dec-07 | Market Purchase | 15,000 | $1.40 | $21,000.00 | 15% 102.15K to 117.15K | (44%) |
| 14-Dec-07 2:52 PM View: | Savage Robert G Director | Immune Pharmaceuticals, Inc. (IMNPQ) | 13-Dec-07 | Market Purchase | 30,000 | $1.38 | $41,338.10 | 20% 150.3K to 180.3K | (43%) |
| 13-Dec-07 5:08 PM View: | Allard Stephane Chief Medical Officer | Immune Pharmaceuticals, Inc. (IMNPQ) | 12-Dec-07 | Market Purchase | 10,000 | $1.41 | $14,100.00 | 14% 71.2K to 81.2K | (44%) |
| 14-Dec-07 1:45 PM View: | Bhagwat Dileep SVP-Pharmaceutical Development | Immune Pharmaceuticals, Inc. (IMNPQ) | 12-Dec-07 | Market Purchase | 10,000 | $1.43 | $14,275.00 | 400% 2.5K to 12.5K | (45%) |
| 13-Dec-07 5:08 PM View: | Allard Stephane Chief Medical Officer | Immune Pharmaceuticals, Inc. (IMNPQ) | 12-Dec-07 | Market Purchase | 1,800 | $1.42 | $2,556.00 | 3% 69.4K to 71.2K | (44%) |
| 14-Dec-07 2:55 PM View: | Wiedemann Oliver Managing Director-See Remarks | Immune Pharmaceuticals, Inc. (IMNPQ) | 12-Dec-07 | Market Purchase | 5,000 | $1.40 | $7,000.00 | 100% 0 to 5.0K | (44%) |
| 13-Dec-07 5:08 PM View: | Allard Stephane Chief Medical Officer | Immune Pharmaceuticals, Inc. (IMNPQ) | 11-Dec-07 | Market Purchase | 33,200 | $1.43 | $47,476.00 | 92% 36.2K to 69.4K | (45%) |
| 13-Dec-07 5:08 PM View: | Allard Stephane Chief Medical Officer | Immune Pharmaceuticals, Inc. (IMNPQ) | 13-Sep-07 | Market Purchase | 600 | $1.62 | $972.00 | 2% 35.6K to 36.2K | (51%) |
| 04-Sep-07 5:02 PM View: | Bedard John F Director | Immune Pharmaceuticals, Inc. (IMNPQ) | 04-Sep-07 | Market Purchase | 2,000 | $1.68 | $3,360.00 | 100% 0 to 2.0K | (53%) |
| 30-Aug-07 4:39 PM View: | Cook Robert W CFO-SVP, Finance & Admin. | Immune Pharmaceuticals, Inc. (IMNPQ) | 30-Aug-07 | Market Purchase | 1,803 | $1.69 | $3,047.10 | 22% 8.2K to 10.0K | (53%) |
| 30-Aug-07 4:39 PM View: | Cook Robert W CFO-SVP, Finance & Admin. | Immune Pharmaceuticals, Inc. (IMNPQ) | 29-Aug-07 | Market Purchase | 8,197 | $1.66 | $13,607.00 | 100% 0 to 8.2K | (52%) |
